Form 8-K

RESMED INC.

Date: November 18, 2016

/s/ David Pendarvis

David Pendarvis

Chief administrative officer, global general counsel and secretary

0001193125-16-772096.txt : 20161118 0001193125-16-772096.hdr.sgml : 20161118 20161118143202 ACCESSION NUMBER: 0001193125-16-772096 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161116 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20161118 DATE AS OF CHANGE: 20161118 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RESMED INC CENTRAL INDEX KEY: 0000943819 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 980152841 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-15317 FILM NUMBER: 162007468 BUSINESS ADDRESS: STREET 1: 9001 SPECTRUM CENTER BLVD. CITY: SAN DIEGO STATE: CA ZIP: 92123 BUSINESS PHONE: 8587462400 MAIL ADDRESS: STREET 1: 9001 SPECTRUM CENTER BLVD. CITY: SAN DIEGO STATE: CA ZIP: 92123 8-K 1 d299408d8k.htm FORM 8-K Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

November 16, 2016

Date of Report (Date of earliest event reported)

ResMed Inc.

(Exact Name of Registrant as Specified in Charter)

Delaware

001-15317

98-0152841

(State or Other Jurisdiction

of Incorporation)

(Commission

File Number)

(I.R.S. Employer

Identification No.)

9001 Spectrum Center Boulevard

San Diego, California 92123

(Address of Principal Executive Offices) (Zip Code)

(858) 836-5000

(Registrant’s telephone number, including area code)

N/A

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.07.

Submission of Matters to a Vote of Security Holders.

On November 16, 2016, US Pacific time, at our annual meeting of stockholders, our stockholders (1) elected the two nominees listed below to serve on our board of directors; (2) ratified the selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2017; and (3) approved the compensation of our named executive officers.


	For		Against		Abstain		Broker Non-Votes
Item of Business No. 1: Elect the following two nominees to serve for three-year terms until our annual meeting of stockholders in 2019:
Carol Burt		100,666,008		289,740		171,373		6,825,559
Rich Sulpizio		99,898,400		1,053,609		175,112		6,825,559

	For		Against		Abstain		Broker Non-Votes
Item No. 2: Ratify KPMG LLP as independent registered public accounting firm.		106,114,765		1,662,706		175,209

	For		Against		Abstain		Broker Non-Votes
Item No. 3: Approve, on an advisory basis, the compensation of ResMed’s named executive officers.		78,988,265		16,493,549		5,645,307		6,825,559

SIGNATURES

We have authorized the person whose signature appears below to sign this report on our behalf, in accordance with the Securities Exchange Act of 1934.